Reliv' International (RELV) 10-Q 14 Aug 18 2018 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2018	Aug. 06, 2018
Document Information [Line Items]
Entity Registrant Name	RELIV INTERNATIONAL INC
Entity Central Index Key	768,710
Trading Symbol	relv
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		1,845,160
Document Type	10-Q
Document Period End Date	Jun. 30, 2018
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 2,764,088	$ 3,272,788
Accounts receivable, less allowances of $25,000 in 2018 and $26,300 in 2017	213,975	29,760
Accounts and note due from employees and distributors	136,142	138,497
Inventories
Finished goods	2,155,494	2,762,249
Raw materials	1,825,096	1,653,466
Sales aids and promotional materials	124,611	139,770
Total inventories	4,105,201	4,555,485
Refundable income taxes	22,936	26,552
Cash surrender value of life insurance, current	3,067,360
Prepaid expenses and other current assets	638,815	372,602
Total current assets	10,948,517	8,395,684
Other assets	338,139	337,190
Cash surrender value of life insurance		3,086,522
Note receivable due from distributor	1,344,513	1,405,113
Intangible assets, net	2,061,256	2,174,248
Property, plant and equipment:
Land and land improvements	905,190	905,190
Building	9,951,041	9,950,190
Machinery & equipment	4,789,933	4,755,727
Office equipment	1,154,955	1,183,115
Computer equipment & software	2,268,208	2,261,038
	19,069,327	19,055,260
Less: Accumulated depreciation	13,627,981	13,378,021
Net property, plant and equipment	5,441,346	5,677,239
Total assets	20,133,771	21,075,996
Accounts payable and accrued expenses:
Trade accounts payable and other accrued expenses	2,304,912	1,667,495
Distributors' commissions payable	1,035,685	1,115,649
Sales taxes payable	135,618	154,958
Deferred revenue	356,028
Payroll and payroll taxes payable	239,386	261,916
Total accounts payable and accrued expenses	4,071,629	3,200,018
Income taxes payable	5,065	12,616
Revolving line of credit	500,000	500,000
Current portion of long-term debt	2,355,861	2,545,421
Total current liabilities	6,932,555	6,258,055
Noncurrent liabilities:
Other noncurrent liabilities	458,750	453,354
Total noncurrent liabilities	458,750	453,354
Stockholders' equity:
Preferred stock, par value $.001 per share; 500,000 shares authorized; -0- shares issued and outstanding in 2018 and 2017	0	0
Common stock, par value $.001 per share; 5,000,000 authorized; 2,110,013 shares issued and 1,845,160 shares outstanding as of 6/30/2018; 2,110,013 shares issued and 1,845,160 shares outstanding as of 12/31/2017	2,110	2,110
Additional paid-in capital	30,613,989	30,598,920
Accumulated deficit	(11,624,056)	(10,040,229)
Accumulated other comprehensive loss:
Foreign currency translation adjustment	(911,017)	(857,654)
Treasury stock	(5,338,560)	(5,338,560)
Total stockholders' equity	12,742,466	14,364,587
Total liabilities and stockholders' equity	$ 20,133,771	$ 21,075,996

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Accounts receivable, allowances	$ 25,000	$ 26,300
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	500,000	500,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	5,000,000	5,000,000
Common stock, shares issued (in shares)	2,110,013	2,110,013
Common stock, shares outstanding (in shares)	1,845,160	1,845,160

Condensed Consolidated Statemen

Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Net sales	$ 8,459,741	$ 10,006,628	$ 18,462,980	$ 22,784,410
Costs and expenses:
Cost of products sold	2,356,274	2,328,452	4,706,016	5,163,977
Distributor royalties and commissions	2,827,357	3,554,773	6,219,102	8,053,326
Selling, general and administrative	4,215,641	4,631,860	8,701,536	9,558,139
Total costs and expenses	9,399,272	10,515,085	19,626,654	22,775,442
Income (loss) from operations	(939,531)	(508,457)	(1,163,674)	8,968
Other income (expense):
Interest income	23,547	25,827	47,499	51,353
Interest expense	(45,222)	(27,448)	(76,787)	(52,289)
Other income	6,252	12,413	16,703	45,096
Income (loss) before income taxes	(954,954)	(497,665)	(1,176,259)	53,128
Provision for income taxes	23,000	22,000	40,000	49,000
Net income (loss)	(977,954)	(519,665)	(1,216,259)	4,128
Other comprehensive income (loss):
Foreign currency translation adjustment	(78,591)	65,162	(53,363)	90,634
Comprehensive income (loss)	$ (1,056,545)	$ (454,503)	$ (1,269,622)	$ 94,762
Earnings (loss) per common share - Basic (in dollars per share)	$ (0.53)	$ (0.28)	$ (0.66)	$ 0
Weighted average shares (in shares)	1,845,000	1,845,000	1,845,000	1,845,000
Earnings (loss) per common share - Diluted (in dollars per share)	$ (0.53)	$ (0.28)	$ (0.66)	$ 0
Weighted average shares (in shares)	1,845,000	1,845,000	1,845,000	1,846,000
Product [Member]
Net sales	$ 7,920,596	$ 9,258,809	$ 17,311,977	$ 21,093,925
Shipping and Handling [Member]
Net sales	$ 539,145	$ 747,819	$ 1,151,003	$ 1,690,485

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Operating activities:
Net income (loss)	$ (1,216,259)	$ 4,128
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	403,430	435,261
Stock-based compensation	15,069	16,888
Non-cash life insurance policy reduction / (accretion)	19,162	(60,270)
(Gain) loss on sale of property, plant and equipment	(2,838)	(11,361)
Deferred income taxes		10,000
Foreign currency transaction (gain) loss	(194)	(35,184)
(Increase) decrease in accounts receivable and accounts due from employees and distributors	(180,145)	40,767
(Increase) decrease in inventories	415,760	112,036
(Increase) decrease in refundable income taxes	3,616	68,516
(Increase) decrease in prepaid expenses and other current assets	(274,252)	(342,897)
(Increase) decrease in other assets	(948)	(24,907)
Increase (decrease) in income taxes payable	(6,930)
Increase (decrease) in accounts payable & accrued expenses and other noncurrent liabilities	568,291	126,216
Net cash provided by (used in) operating activities	(256,238)	339,193
Investing activities:
Purchase of property, plant and equipment	(56,968)	(403,910)
Proceeds from the sale of property, plant and equipment	3,888	11,900
Payments received on distributor note receivable	57,079	53,763
Net cash provided by (used in) investing activities	3,999	(338,247)
Financing activities:
Principal payments on long-term borrowings	(189,560)	(228,336)
Net cash used in financing activities	(189,560)	(228,336)
Effect of exchange rate changes on cash and cash equivalents	(66,901)	69,501
Increase (decrease) in cash and cash equivalents	(508,700)	(157,889)
Cash and cash equivalents at beginning of period	3,272,788	3,606,817
Cash and cash equivalents at end of period	$ 2,764,088	$ 3,448,928

Note 1 - Accounting Policies

Note 1 - Accounting Policies	6 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
Significant Accounting Policies [Text Block]	1. Accounting Polic ies Basis of Presentation The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10 not may not may 10 December 31, 2017, March 29, 2018 Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. New Accounting Pronouncements – Not In February 2016, No. 2016 2, Leases (Topic 842 twelve December 15, 2018 not New Accounting Pronouncements – Adopted January 1, 2018 On January 1, 2018, No. 2014 09, Revenue from Contracts with Customers not $367,568 zero In accordance with the new revenue standard requirements, the disclosure of the impact of adoption to the Company’s financial position and results from operations are as follows: Balance at Adjustments Balance at December 31 Due to January 1 2017 ASU 2014-09 2018 Liabilities and stockholders' equity Accumulated deficit $ (10,040,229 ) $ (367,568 ) $ (10,407,797 ) Deferred revenue - 367,568 367,568 Three Months Ended June 30, 2018 Without Effect of Adoption of Change As Reported ASU 2014-09 Higher/(Lower) Operating results Net sales $ 8,459,741 $ 8,460,954 $ (1,213 ) Net income (loss) (977,954 ) (976,741 ) (1,213 ) Six Months Ended June 30, 2018 Without Effect of Adoption of Change As Reported ASU 2014-09 Higher/(Lower) Operating results Net sales $ 18,462,980 $ 18,452,001 $ 10,979 Net income (loss) (1,216,259 ) (1,227,238 ) 10,979 The new revenue standard defines a five twelve December 31, 2017, $367,568. Prior to adoption of the new revenue standard, the Company’s primary source of revenue has been from the sale of nutritional products to the Company’s independent distributors whereby revenue is recognized when product is shipped and risk of loss has passed to the customer; and the Company’s nutritional product revenue recognition policy does not The Company does not Description of Products and Services by Region and Category The Company operates in one six Three months ended June 30 Six months ended June 30 2018 2017 2018 2017 Net sales to external customers United States $ 6,336,387 $ 7,449,858 $ 14,006,448 $ 17,708,797 Australia/New Zealand 177,536 227,032 409,464 486,458 Canada 161,557 217,085 403,677 481,388 Mexico 112,411 89,221 219,782 246,538 Europe (1) 1,030,546 1,307,383 2,195,430 2,508,158 Asia (2) 641,304 716,049 1,228,179 1,353,071 Total net sales $ 8,459,741 $ 10,006,628 $ 18,462,980 $ 22,784,410 ( 1 Europe consists of United Kingdom, Ireland, France, Germany, Austria, and the Netherlands. ( 2 Asia consists of Philippines, Malaysia, Singapore, and Indonesia. The Company classifies its sales into two Three months ended June 30 Six months ended June 30 2018 2017 2018 2017 Net sales by product category Nutritional and dietary supplements $ 7,606,674 $ 8,917,319 $ 16,676,031 $ 20,336,938 Sales aids and other 313,922 341,490 635,946 756,987 Handling & freight income 539,145 747,819 1,151,003 1,690,485 Total net sales $ 8,459,741 $ 10,006,628 $ 18,462,980 $ 22,784,410

Note 2 - Basic and Diluted Earn

Note 2 - Basic and Diluted Earnings (Loss) Per Share	6 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
Earnings Per Share [Text Block]	2. Basic earnings (loss) per common share is computed using the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per common share is computed using the weighted average number of common shares and potential dilutive common shares that were outstanding during the period. Potential dilutive common shares consist of outstanding stock options, outstanding stock warrants, and convertible preferred stock. The following table sets forth the computation of basic and diluted earnings (loss) per share: Three months ended June 30 Six months ended June 30 2018 2017 2018 2017 Numerator: Net income (loss) $ (977,954 ) $ (519,665 ) $ (1,216,259 ) $ 4,128 Denominator: Denominator for basic earnings (loss) per share – weighted average shares 1,845,000 1,845,000 1,845,000 1,845,000 Dilutive effect of employee stock options and other warrants - - - 1,000 Denominator for diluted earnings (loss) per share – adjusted weighted average shares 1,845,000 1,845,000 1,845,000 1,846,000 Basic earnings (loss) per share $ (0.53 ) $ (0.28 ) $ (0.66 ) $ 0.00 Diluted earnings (loss) per share $ (0.53 ) $ (0.28 ) $ (0.66 ) $ 0.00 Options and warrants to purchase 120,242 three six June 30, 2018, not 146,715 142,013 three six June 30, 2017, not

Note 3 - Fair Value of Financia

Note 3 - Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
Fair Value Disclosures [Text Block]	3 . Fair Value of Financial Instruments Fair value can be measured using valuation techniques such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). Accounting standards utilize a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three Level 1: Level 2: not Level 3: The carrying amount and fair value of financial instruments were approximately as follows: Carrying Fair Description Amount Value Level 1 Level 2 Level 3 June 30, 2018 Long-term debt $ 2,855,861 $ 2,855,861 - $ 2,855,861 - Note receivable 1,463,926 1,579,000 - 1,579,000 - Marketable securities 331,000 331,000 $ 331,000 - - December 31, 2017 Long-term debt $ 3,045,421 $ 3,045,421 - $ 3,045,421 - Note receivable 1,521,005 1,684,000 - 1,684,000 - Marketable securities 330,000 330,000 $ 330,000 - - Long-term debt thirty Note receivable fifteen Marketable securities The carrying value of other financial instruments, including cash, accounts receivable and accounts payable, and accrued liabilities approximate fair value due to their short maturities or variable-rate nature of the respective balances.

Note 4 - Debt - Subsequent Even

Note 4 - Debt - Subsequent Events	6 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
Debt Disclosure [Text Block]	4 . Debt – Subsequent Events June 30 December 31 2018 2017 Term loan $ 2,355,861 $ 2,545,421 Revolving line of credit 500,000 500,000 2,855,861 3,045,421 Less current portion 2,855,861 3,045,421 Total long-term debt $ - $ - The original September 30, 2015 $3.25 ten $27,080 September 30, 2018. April 11, 2018 September 30, 2018 April 29, 2019. 30 2.25% 4.26% June 30, 2018. Effective with an April 11, 2018 April 30, 2018 April 29, 2019 $3.5 $2.0 June 30, 2018, $500,000. Borrowings under the lending agreements continued to be secured by all tangible and intangible assets of the Company, a whole life insurance policy on the life of the Company's Chief Executive Officer, which was assigned to the lender, and by a mortgage on the real estate of the Company's headquarters. The loan agreements, including the April 2018 not $9.5 $400,000; $600,000; $800,000 June 30, 2018; September 30, 2018; December 31, 2018; $200,000 March 31, 2019. As defined, EBITDA equals the Company's consolidated net income for such period, before interest expense, income tax expense, depreciation and amortization, and management fees, and further adjusted to exclude any gain or loss on the sale of assets, other extraordinary gains or losses, and any one At June 30, 2018, July 2018, $3.07 $2.86 July 2018 zero July 2018 June 30, 2018 June 30, 2018

Note 5 - Income Taxes

Note 5 - Income Taxes	6 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
Income Tax Disclosure [Text Block]	5 . Income Taxes During 2016 2017, not 2016 2017 not In prior years, the Company recorded a valuation allowance on all of its domestic and foreign deferred tax assets. The effective income tax rate was ( 3.4 92.2% six June 30, 2018 2017, six June 30, 2018 2017, one The United States Tax Cuts and Jobs Act (TCJA) was enacted in December 2017, 21% January 1, 2018, 21% Securities and Exchange Commission (“SEC”) issued Staff Accounting Bulletin (“SAB”) 118 118, One of the Company’s foreign subsidiaries is presently under local country audit for alleged deficiencies (totaling approximately $800,000 20% 2004 2006. not 2011, $173,000 As of December 31, 2017, $181,000 first 2018. May 2018, one not

Note 6 - Restructuring Activiti

Note 6 - Restructuring Activities	6 Months Ended
	Jun. 30, 2018
Notes to Financial Statements
Restructuring and Related Activities Disclosure [Text Block]	6 . Restructuring Activities In April 2018, June 30, 2018 $77,000, June 30, 2018. At June 30, 2018, $14,000. 2018.

Significant Accounting Policies

Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with the instructions to Form 10 not may not may 10 December 31, 2017, March 29, 2018
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
New Accounting Pronouncements, Policy [Policy Text Block]	New Accounting Pronouncements – Not In February 2016, No. 2016 2, Leases (Topic 842 twelve December 15, 2018 not New Accounting Pronouncements – Adopted January 1, 2018 On January 1, 2018, No. 2014 09, Revenue from Contracts with Customers not $367,568 zero In accordance with the new revenue standard requirements, the disclosure of the impact of adoption to the Company’s financial position and results from operations are as follows: Balance at Adjustments Balance at December 31 Due to January 1 2017 ASU 2014-09 2018 Liabilities and stockholders' equity Accumulated deficit $ (10,040,229 ) $ (367,568 ) $ (10,407,797 ) Deferred revenue - 367,568 367,568 Three Months Ended June 30, 2018 Without Effect of Adoption of Change As Reported ASU 2014-09 Higher/(Lower) Operating results Net sales $ 8,459,741 $ 8,460,954 $ (1,213 ) Net income (loss) (977,954 ) (976,741 ) (1,213 ) Six Months Ended June 30, 2018 Without Effect of Adoption of Change As Reported ASU 2014-09 Higher/(Lower) Operating results Net sales $ 18,462,980 $ 18,452,001 $ 10,979 Net income (loss) (1,216,259 ) (1,227,238 ) 10,979 The new revenue standard defines a five twelve December 31, 2017, $367,568. Prior to adoption of the new revenue standard, the Company’s primary source of revenue has been from the sale of nutritional products to the Company’s independent distributors whereby revenue is recognized when product is shipped and risk of loss has passed to the customer; and the Company’s nutritional product revenue recognition policy does not The Company does not Description of Products and Services by Region and Category The Company operates in one six Three months ended June 30 Six months ended June 30 2018 2017 2018 2017 Net sales to external customers United States $ 6,336,387 $ 7,449,858 $ 14,006,448 $ 17,708,797 Australia/New Zealand 177,536 227,032 409,464 486,458 Canada 161,557 217,085 403,677 481,388 Mexico 112,411 89,221 219,782 246,538 Europe (1) 1,030,546 1,307,383 2,195,430 2,508,158 Asia (2) 641,304 716,049 1,228,179 1,353,071 Total net sales $ 8,459,741 $ 10,006,628 $ 18,462,980 $ 22,784,410 ( 1 Europe consists of United Kingdom, Ireland, France, Germany, Austria, and the Netherlands. ( 2 Asia consists of Philippines, Malaysia, Singapore, and Indonesia. The Company classifies its sales into two Three months ended June 30 Six months ended June 30 2018 2017 2018 2017 Net sales by product category Nutritional and dietary supplements $ 7,606,674 $ 8,917,319 $ 16,676,031 $ 20,336,938 Sales aids and other 313,922 341,490 635,946 756,987 Handling & freight income 539,145 747,819 1,151,003 1,690,485 Total net sales $ 8,459,741 $ 10,006,628 $ 18,462,980 $ 22,784,410

Note 1 - Accounting Policies (T

Note 1 - Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2018
Notes Tables
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]	Balance at Adjustments Balance at December 31 Due to January 1 2017 ASU 2014-09 2018 Liabilities and stockholders' equity Accumulated deficit $ (10,040,229 ) $ (367,568 ) $ (10,407,797 ) Deferred revenue - 367,568 367,568 Three Months Ended June 30, 2018 Without Effect of Adoption of Change As Reported ASU 2014-09 Higher/(Lower) Operating results Net sales $ 8,459,741 $ 8,460,954 $ (1,213 ) Net income (loss) (977,954 ) (976,741 ) (1,213 ) Six Months Ended June 30, 2018 Without Effect of Adoption of Change As Reported ASU 2014-09 Higher/(Lower) Operating results Net sales $ 18,462,980 $ 18,452,001 $ 10,979 Net income (loss) (1,216,259 ) (1,227,238 ) 10,979
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	Three months ended June 30 Six months ended June 30 2018 2017 2018 2017 Net sales to external customers United States $ 6,336,387 $ 7,449,858 $ 14,006,448 $ 17,708,797 Australia/New Zealand 177,536 227,032 409,464 486,458 Canada 161,557 217,085 403,677 481,388 Mexico 112,411 89,221 219,782 246,538 Europe (1) 1,030,546 1,307,383 2,195,430 2,508,158 Asia (2) 641,304 716,049 1,228,179 1,353,071 Total net sales $ 8,459,741 $ 10,006,628 $ 18,462,980 $ 22,784,410
Schedule of Segment Reporting Information by Product [Table Text Block]	Three months ended June 30 Six months ended June 30 2018 2017 2018 2017 Net sales by product category Nutritional and dietary supplements $ 7,606,674 $ 8,917,319 $ 16,676,031 $ 20,336,938 Sales aids and other 313,922 341,490 635,946 756,987 Handling & freight income 539,145 747,819 1,151,003 1,690,485 Total net sales $ 8,459,741 $ 10,006,628 $ 18,462,980 $ 22,784,410

Note 2 - Basic and Diluted Ea14

Note 2 - Basic and Diluted Earnings (Loss) Per Share (Tables)	6 Months Ended
	Jun. 30, 2018
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three months ended June 30 Six months ended June 30 2018 2017 2018 2017 Numerator: Net income (loss) $ (977,954 ) $ (519,665 ) $ (1,216,259 ) $ 4,128 Denominator: Denominator for basic earnings (loss) per share – weighted average shares 1,845,000 1,845,000 1,845,000 1,845,000 Dilutive effect of employee stock options and other warrants - - - 1,000 Denominator for diluted earnings (loss) per share – adjusted weighted average shares 1,845,000 1,845,000 1,845,000 1,846,000 Basic earnings (loss) per share $ (0.53 ) $ (0.28 ) $ (0.66 ) $ 0.00 Diluted earnings (loss) per share $ (0.53 ) $ (0.28 ) $ (0.66 ) $ 0.00

Note 3 - Fair Value of Financ15

Note 3 - Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2018
Notes Tables
Fair Value, by Balance Sheet Grouping [Table Text Block]	Carrying Fair Description Amount Value Level 1 Level 2 Level 3 June 30, 2018 Long-term debt $ 2,855,861 $ 2,855,861 - $ 2,855,861 - Note receivable 1,463,926 1,579,000 - 1,579,000 - Marketable securities 331,000 331,000 $ 331,000 - - December 31, 2017 Long-term debt $ 3,045,421 $ 3,045,421 - $ 3,045,421 - Note receivable 1,521,005 1,684,000 - 1,684,000 - Marketable securities 330,000 330,000 $ 330,000 - -

Note 4 - Debt - Subsequent Ev16

Note 4 - Debt - Subsequent Events (Tables)	6 Months Ended
	Jun. 30, 2018
Notes Tables
Schedule of Debt [Table Text Block]	June 30 December 31 2018 2017 Term loan $ 2,355,861 $ 2,545,421 Revolving line of credit 500,000 500,000 2,855,861 3,045,421 Less current portion 2,855,861 3,045,421 Total long-term debt $ - $ -

Note 1 - Accounting Policies (D

Note 1 - Accounting Policies (Details Textual)	6 Months Ended
	Jun. 30, 2018USD ($)	Jan. 01, 2018USD ($)
Contract with Customer, Liability, Total	$ 367,568
Number of Reportable Segments	1
Number of Operating Segments	6
Accounting Standards Update 2014-09 [Member]
New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets		$ (367,568)

Note 1 - Accounting Policies -

Note 1 - Accounting Policies - Adoption of ASU No. 2014-09, Financial Position Impact (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017	Jan. 01, 2018	Dec. 31, 2017
Accumulated deficit	$ (11,624,056)		$ (11,624,056)		$ (10,407,797)	$ (10,040,229)
Deferred revenue	356,028		356,028		367,568
Net sales to external customers	8,459,741	$ 10,006,628	18,462,980	$ 22,784,410
Net income (loss)	(977,954)	$ (519,665)	(1,216,259)	$ 4,128
Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Net sales to external customers	8,460,954		18,452,001
Net income (loss)	(976,741)		(1,227,238)
Difference between Revenue Guidance in Effect before and after Topic 606 [Member]
Net sales to external customers	(1,213)		10,979
Net income (loss)	$ (1,213)		$ 10,979
Accounting Standards Update 2014-09 [Member]
Accumulated deficit					(367,568)
Deferred revenue					$ 367,568

Note 1 - Accounting Policies 19

Note 1 - Accounting Policies - Summary of Geographic Area Data (Details) - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Net sales to external customers
Net sales to external customers		$ 8,459,741	$ 10,006,628	$ 18,462,980	$ 22,784,410
UNITED STATES
Net sales to external customers
Net sales to external customers		6,336,387	7,449,858	14,006,448	17,708,797
Australia, New Zealand [Member]
Net sales to external customers
Net sales to external customers		177,536	227,032	409,464	486,458
CANADA
Net sales to external customers
Net sales to external customers		161,557	217,085	403,677	481,388
MEXICO
Net sales to external customers
Net sales to external customers		112,411	89,221	219,782	246,538
Europe [Member]
Net sales to external customers
Net sales to external customers	[1]	1,030,546	1,307,383	2,195,430	2,508,158
Asia [Member]
Net sales to external customers
Net sales to external customers	[2]	$ 641,304	$ 716,049	$ 1,228,179	$ 1,353,071
[1]	Europe consists of United Kingdom, Ireland, France, Germany, Austria, and the Netherlands.
[2]	Asia consists of Philippines, Malaysia, Singapore, and Indonesia.

Note 1 - Accounting Policies 20

Note 1 - Accounting Policies - Net Sales by Product Category (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Net sales to external customers	$ 8,459,741	$ 10,006,628	$ 18,462,980	$ 22,784,410
Nutritional and Dietary Supplements [Member]
Net sales to external customers	7,606,674	8,917,319	16,676,031	20,336,938
Sales Aids and Other [Member]
Net sales to external customers	313,922	341,490	635,946	756,987
Handling and Freight Income [Member]
Net sales to external customers	$ 539,145	$ 747,819	$ 1,151,003	$ 1,690,485

Note 2 - Basic and Diluted Ea21

Note 2 - Basic and Diluted Earnings (Loss) Per Share (Details Textual) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	120,242	146,715	120,242	142,013

Note 2 - Basic and Diluted Ea22

Note 2 - Basic and Diluted Earnings (Loss) Per Share - Basic and Diluted Earnings (Loss) Per Share (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Net income (loss)	$ (977,954)	$ (519,665)	$ (1,216,259)	$ 4,128
Denominator for basic earnings (loss) per share – weighted average shares (in shares)	1,845,000	1,845,000	1,845,000	1,845,000
Dilutive effect of employee stock options and other warrants (in shares)				1,000
Denominator for diluted earnings (loss) per share – adjusted weighted average shares (in shares)	1,845,000	1,845,000	1,845,000	1,846,000
Basic earnings (loss) per share (in dollars per share)	$ (0.53)	$ (0.28)	$ (0.66)	$ 0
Diluted earnings (loss) per share (in dollars per share)	$ (0.53)	$ (0.28)	$ (0.66)	$ 0

Note 3 - Fair Value of Financ23

Note 3 - Fair Value of Financial Instruments - Summary of Financial Instruments (Details) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Long-term debt	$ 2,855,861	$ 3,045,421
Long-term debt, fair value	2,855,861	3,045,421
Note receivable	1,463,926	1,521,005
Note receivable, fair value	1,579,000	1,684,000
Marketable securities	331,000	330,000
Fair Value, Inputs, Level 1 [Member]
Long-term debt, fair value
Note receivable, fair value
Marketable securities	331,000	330,000
Fair Value, Inputs, Level 2 [Member]
Long-term debt, fair value	2,855,861	3,045,421
Note receivable, fair value	1,579,000	1,684,000
Marketable securities
Fair Value, Inputs, Level 3 [Member]
Long-term debt, fair value
Note receivable, fair value
Marketable securities

Note 4 - Debt - Subsequent Ev24

Note 4 - Debt - Subsequent Events (Details Textual) - USD ($)	Sep. 30, 2015	Jul. 31, 2018	Mar. 31, 2019	Jun. 30, 2018	Sep. 30, 2018	Dec. 31, 2018	Apr. 11, 2018	Dec. 31, 2017
Debt Instrument, Covenant Compliance, Minimum Net Tangible Worth				$ 9,500,000
Line of Credit Facility, Covenant Compliance, Minimum Cumulative EBITDA				400,000
Cash Surrender Value of Life Insurance, Current				3,067,360
Loans Payable, Current, Total				2,355,861				2,545,421
Line of Credit, Current				500,000				500,000
Cash Surrender Value of Life Insurance								$ 3,086,522
Subsequent Event [Member]
Repayments of Debt		$ 2,860,000
Cash Surrender Value of Life Insurance		0
Scenario, Forecast [Member]
Line of Credit Facility, Covenant Compliance, Minimum Cumulative EBITDA			$ 200,000		$ 600,000	$ 800,000
Revolving Credit Facility [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 3,500,000						$ 2,000,000
Long-term Line of Credit, Total				$ 500,000
Term Loan [Member]
Debt Instrument, Face Amount	$ 3,250,000
Debt Instrument, Amortization Term	10 years
Debt Instrument, Periodic Payment, Principal	$ 27,080
Debt Instrument, Interest Rate, Effective Percentage				4.26%
Term Loan [Member] | Subsequent Event [Member]
Loans Payable, Current, Total		0
Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member]
Debt Instrument, Basis Spread on Variable Rate	2.25%
Line of Credit [Member] | Subsequent Event [Member]
Line of Credit, Current		$ 0

Note 4 - Debt - Subsequent Ev25

Note 4 - Debt - Subsequent Events - Summary of Debt (Details) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Long-term debt	$ 2,855,861	$ 3,045,421
Less current portion	2,855,861	3,045,421
Total long-term debt
Term Loan [Member]
Long-term debt	2,355,861	2,545,421
Line of Credit [Member]
Long-term debt	$ 500,000	$ 500,000

Note 5 - Income Taxes (Details

Note 5 - Income Taxes (Details Textual) - USD ($)	6 Months Ended		12 Months Ended	36 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2011	Dec. 31, 2006	Dec. 31, 2017
Effective Income Tax Rate Reconciliation, Percent, Total	(3.40%)	92.20%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	21.00%
VAT and Withholding Taxes				$ 800,000
Interest Penalty Percentage				20.00%
Payments for Good Faith Deposits to Local Tax Authority Under Tax Agency's Adminstrative Judicial Resolution Process			$ 173,000
Reserve for Tax Deficiencies of Subsidiaries [Member]
Loss Contingency Accrual, Ending Balance					$ 181,000

Note 6 - Restructuring Activi27

Note 6 - Restructuring Activities (Details Textual) - Closing of Reliv Indonesia Subsidiary [Member]	3 Months Ended
	Jun. 30, 2018USD ($)
Restructuring Charges, Total	$ 77,000
Restructuring Reserve, Ending Balance	$ 14,000